198 related articles for article (PubMed ID: 17440061)
1. Malignant glioma cells counteract antitumor immune responses through expression of lectin-like transcript-1.
Roth P; Mittelbronn M; Wick W; Meyermann R; Tatagiba M; Weller M
Cancer Res; 2007 Apr; 67(8):3540-4. PubMed ID: 17440061
[TBL] [Abstract][Full Text] [Related]
2. RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo.
Friese MA; Wischhusen J; Wick W; Weiler M; Eisele G; Steinle A; Weller M
Cancer Res; 2004 Oct; 64(20):7596-603. PubMed ID: 15492287
[TBL] [Abstract][Full Text] [Related]
3. TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells.
Eisele G; Wischhusen J; Mittelbronn M; Meyermann R; Waldhauer I; Steinle A; Weller M; Friese MA
Brain; 2006 Sep; 129(Pt 9):2416-25. PubMed ID: 16891318
[TBL] [Abstract][Full Text] [Related]
4. Macrophage migration inhibitory factor (MIF) expression in human malignant gliomas contributes to immune escape and tumour progression.
Mittelbronn M; Platten M; Zeiner P; Dombrowski Y; Frank B; Zachskorn C; Harter PN; Weller M; Wischhusen J
Acta Neuropathol; 2011 Sep; 122(3):353-65. PubMed ID: 21773885
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer cells inhibits NK cell-mediated killing through LLT1-NKRP1A (CD161) interaction.
Mathew SO; Chaudhary P; Powers SB; Vishwanatha JK; Mathew PA
Oncotarget; 2016 Oct; 7(42):68650-68661. PubMed ID: 27626681
[TBL] [Abstract][Full Text] [Related]
6. Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity.
Kopp HG; Placke T; Salih HR
Cancer Res; 2009 Oct; 69(19):7775-83. PubMed ID: 19738039
[TBL] [Abstract][Full Text] [Related]
7. Induction of lectin-like transcript 1 (LLT1) protein cell surface expression by pathogens and interferon-γ contributes to modulate immune responses.
Germain C; Meier A; Jensen T; Knapnougel P; Poupon G; Lazzari A; Neisig A; Håkansson K; Dong T; Wagtmann N; Galsgaard ED; Spee P; Braud VM
J Biol Chem; 2011 Nov; 286(44):37964-37975. PubMed ID: 21930700
[TBL] [Abstract][Full Text] [Related]
8. GDF-15 contributes to proliferation and immune escape of malignant gliomas.
Roth P; Junker M; Tritschler I; Mittelbronn M; Dombrowski Y; Breit SN; Tabatabai G; Wick W; Weller M; Wischhusen J
Clin Cancer Res; 2010 Aug; 16(15):3851-9. PubMed ID: 20534737
[TBL] [Abstract][Full Text] [Related]
9. Aryl hydrocarbon receptor inhibition downregulates the TGF-beta/Smad pathway in human glioblastoma cells.
Gramatzki D; Pantazis G; Schittenhelm J; Tabatabai G; Köhle C; Wick W; Schwarz M; Weller M; Tritschler I
Oncogene; 2009 Jul; 28(28):2593-605. PubMed ID: 19465936
[TBL] [Abstract][Full Text] [Related]
10. Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastoma.
Wischhusen J; Jung G; Radovanovic I; Beier C; Steinbach JP; Rimner A; Huang H; Schulz JB; Ohgaki H; Aguzzi A; Rammensee HG; Weller M
Cancer Res; 2002 May; 62(9):2592-9. PubMed ID: 11980654
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of extracellular domain of human lectin-like transcript 1 (LLT1), the ligand for natural killer receptor-P1A.
Kita S; Matsubara H; Kasai Y; Tamaoki T; Okabe Y; Fukuhara H; Kamishikiryo J; Krayukhina E; Uchiyama S; Ose T; Kuroki K; Maenaka K
Eur J Immunol; 2015 Jun; 45(6):1605-13. PubMed ID: 25826155
[TBL] [Abstract][Full Text] [Related]
12. Expression and purification of soluble and stable ectodomain of natural killer cell receptor LLT1 through high-density transfection of suspension adapted HEK293S GnTI(-) cells.
Bláha J; Pachl P; Novák P; Vaněk O
Protein Expr Purif; 2015 May; 109():7-13. PubMed ID: 25623399
[TBL] [Abstract][Full Text] [Related]
13. Sodium butyrate upregulates expression of NKG2D ligand MICA/B in HeLa and HepG2 cell lines and increases their susceptibility to NK lysis.
Zhang C; Wang Y; Zhou Z; Zhang J; Tian Z
Cancer Immunol Immunother; 2009 Aug; 58(8):1275-85. PubMed ID: 19139882
[TBL] [Abstract][Full Text] [Related]
14. Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor.
Aldemir H; Prod'homme V; Dumaurier MJ; Retiere C; Poupon G; Cazareth J; Bihl F; Braud VM
J Immunol; 2005 Dec; 175(12):7791-5. PubMed ID: 16339512
[TBL] [Abstract][Full Text] [Related]
15. Docetaxel suppresses immunotherapy efficacy of natural killer cells toward castration-resistant prostate cancer cells via altering androgen receptor-lectin-like transcript 1 signals.
Tang M; Gao S; Zhang L; Liu B; Li J; Wang Z; Zhang W
Prostate; 2020 Jul; 80(10):742-752. PubMed ID: 32449811
[TBL] [Abstract][Full Text] [Related]
16. Biological and Clinical Significance of Human NKRP1A/LLT1 Receptor/Ligand Interactions.
Bialoszewska A; Malejczyk J
Crit Rev Immunol; 2018; 38(6):479-489. PubMed ID: 31002602
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis for LLT1 protein recognition by human CD161 protein (NKRP1A/KLRB1).
Kamishikiryo J; Fukuhara H; Okabe Y; Kuroki K; Maenaka K
J Biol Chem; 2011 Jul; 286(27):23823-30. PubMed ID: 21572041
[TBL] [Abstract][Full Text] [Related]
18. Glioma gene therapy with soluble transforming growth factor-beta receptors II and III.
Naumann U; Maass P; Gleske AK; Aulwurm S; Weller M; Eisele G
Int J Oncol; 2008 Oct; 33(4):759-65. PubMed ID: 18813789
[TBL] [Abstract][Full Text] [Related]
19. Good news, bad news for missing-self recognition by NK cells: autoimmune control but viral evasion.
Vivier E; Romagné F
Immunity; 2007 May; 26(5):549-51. PubMed ID: 17521583
[TBL] [Abstract][Full Text] [Related]
20. LLT1-mediated activation of IFN-gamma production in human natural killer cells involves ERK signalling pathway.
Bambard ND; Mathew SO; Mathew PA
Scand J Immunol; 2010 Mar; 71(3):210-9. PubMed ID: 20415786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
